Up-regulated renal expression of TNF-α signalling adapter proteins in lupus glomerulonephritis

Lupus

Volumn 18, Issue 2, 2009, Pages 116-127

  Zhu, L ^a   Yang, X ^a   Ji, Y ^a   Chen, W ^a   Guan, W ^a   Zhou, S F ^b   Yu, X ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Adapter protein; Immunohistologic analysis; Lupus nephritis; Signal transduction; TNF

Indexed keywords

CD68 ANTIGEN, HUMAN; CYCLINE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ADULT; ARTICLE; CASE CONTROL STUDY; FEMALE; GLOMERULUS; HUMAN; KIDNEY TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; METABOLISM; MIDDLE AGED; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 65349159772     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203308094764     Document Type: Article

References (44)

1. D'Cruz, DP, Khamashta, MA, Hughes, GR. Systemic lupus erythematosus. Lancet 2007; 369: 587-596.
2. Alexopoulos, E, Seron, D, Hartley, RB, Cameron, JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990; 37: 100-109.
3. Schwartz, MM. The pathology of lupus nephritis. Semin Nephrol 2007; 27: 22-34.
4. Agrawal, N, Chiang, LK, Rifkin, IR. Lupus nephritis. Semin Nephrol 2006; 26: 95-104.
5. Lewis, EJ, Schwartz, MM. Pathology of lupus nephritis. Lupus 2005; 14: 31-38.
6. Cameron, JS. Lupus nephritis. J Am Soc Nephrol 1999; 10: 413-424.
7. Vielhauer, V, Mayadas, TN. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol 2007; 27: 286-308.
8. Aringer, M, Smolen, JS. Cytokine expression in lupus kidneys. Lupus 2005; 14: 13-18.
9. Studnicka-Benke, A, Steiner, G, Petera, P, Smolen, JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 1067-1074.
10. Takemura, T, Yoshioka, K, Murakami, K, et al. Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch 1994; 424: 459-464.
11. Herrera-Esparza, R, Barbosa-Cisneros, O, Villalobos-Hurtado, R, Avalos-Diaz, E. Renal expression of IL-6 and TNFalpha genes in lupus nephritis. Lupus 1998; 7: 154-158.
12. Aringer, M, Smolen, JS. SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. Arthritis Res Ther 2003; 5: 172-177.
13. Flanc, RS, Roberts, MA, Strippoli, GF, Chadban, SJ, Kerr, PG, Atkins, RC. Treatment for lupus nephritis. Cochrane Database Syst Rev 2004; XXX: CD002922.
14. Aringer, M, Smolen, JS. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus 2004; 13: 344-347.
15. Kollias, G, Kontoyiannis, D. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev 2002; 13: 315-321.
16. Locksley, RM, Killeen, N, Lenardo, MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501.
17. Ting, AT, Pimentel-Muiños, FX, Seed, B. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J 1996; 15: 6189-6196.
18. Zhu, L, Yang, X, Chen, W, et al. Decreased expressions of the TNFalpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus. Clin Rheumatol 2007; 26: 1481-1489.
19. Li, ZR, Hromchak, R, Mudipalli, A, Bloch, A. Tumor suppressor proteins as regulators of cell differentiation. Cancer Res 1998; 58: 4282-4287.
20. Shin, DM, Voravud, N, Ro, JY, Lee, JS, Hong, WK, Hittelman, WN. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Inst 1993; 85: 971-978.
21. Iyengar, B. Expression of proliferating cell nuclear antigen (PCNA): proliferative phase functions and malignant transformation of melanocytes. Melanoma Res 1994; 4: 293-295.
22. Petri, M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am 2005; 31: 245-254 vi.
23. Font, J, Cervera, R. 1982 revised criteria for classification of systemic lupus erythematosus-ten years later. Lupus 1993; 2: 339-341 discussion 343.
24. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
25. Bombardier, C, Gladman, DD, Urowitz, MB, Caron, D, Chang, CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
26. Weening, JJ, DAgati, VD, Schwartz, MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250.
27. Weening, JJ, DAgati, VD, Schwartz, MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530.
28. Pirani, C.L. S-M, Koss, M. Evaluationof renal biopsy. In: Sommers, C, (ed), Decennial, Pathology, (1965-1975). 1st ed. New York: Appleton Century Crofts; 1975, 109-163.
29. Austin, HA 3rd, Muenz, LR, Joyce, KM, Antonovych, TT, Balow, JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689-695.
30. Baud, V, Karin, M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11: 372-377.
31. Wu, AJ, Hua, H, Munson, SH, McDevitt, HO. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci U S A 2002; 99: 12287-12292.
32. Malide, D, Russo, P, Bendayan, M. Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol 1995; 26: 558-564.
33. Hsu, H, Xiong, J, Goeddel, DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995; 81: 495-504.
34. Hsu, H, Shu, HB, Pan, MG, Goeddel, DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84: 299-308.
35. Hsu, H, Huang, J, Shu, HB, Baichwal, V, Goeddel, DV. TNFdependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996; 4: 387-396.
36. Chinnaiyan, AM, ORourke, K, Tewari, M, Dixit, VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505-512.
37. Liu, ZG, Hsu, H, Goeddel, DV, Karin, M. Dissection of TNF receptor 1. effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996; 87: 565-576.
38. Zhang, J, Cado, D, Chen, A, Kabra, NH, Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 392: 296-300.
39. Darnay, BG, Aggarwal, BB. Early events in TNF signaling: a story of associations and dissociations. J Leukoc Biol 1997; 61: 559-566.
40. Rothe, M, Pan, MG, Henzel, WJ, Ayres, TM, Goeddel, DV. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995; 83: 1243-1252.
41. Yu, CC, Filipe, MI. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J 1993; 25: 843-853.
42. Waseem, NH, Lane, DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 1990; 96: 121-129.
43. Dreinhofer, KE, Akerman, M, Willen, H, Anderson, C, Gustafson, P, Rydholm, A. Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: prognostic value in 48 patients. Int J Cancer 1994; 59: 379-382.
44. Nath, KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17.